EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology

Qiuling Wu, Qilong Zhou, Chengyu Wan, Guang Xin, Tao Wang iD, Yu Gao iD, Ting Liu, Xiuxian Yu, Boli Zhang, Wen Huang

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251810063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Qiuling Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Natural and Biomimetic Medicine Research Center, Tissue-Orientated Property of Chinese Medicine Key Laboratory of Sichuan Province, West China School…. Hauptthemen laut MEDLINE: Hypertension, Renovascular, Network Pharmacology. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Innovative Chinese Medicine and Health Products Research Academician Workstation of Academicians Boli Zhang and Beiwei Zhu of the West China Hospital, Sich…, the 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University, the Innovative Chinese Medicine Preclinical Research Fund of "Liqing No.2", West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renovascular hypertension (RH), a secondary hypertension, can significantly impact heart health, resulting in heart damage and dysfunction, thereby elevating the risk of cardiovascular diseases. Coniferol (CA), which has vascular relaxation properties, is expected to be able to treat hypertension-related diseases. However, its potential effects on cardiac function after RH remain unclear. In this study, in combination with network pharmacology, the antihypertensive and cardioprotective effects of CA in a two-kidney, one-clip (2K1C) mice model and its ability to mitigate angiotensin II (Ang II)-induced hypertrophy in H9C2 cells were investigated. The findings revealed that CA effectively reduced blood pressure, myocardial tissue damage, and inflammation after RH. The possible targets of CA for RH treatment were screened by network pharmacology. The interleukin-17 (IL-17) and tumor necrosis factor (TNF) signaling pathways were identified using a Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. The inflammatory response was identified using a Gene Ontology (GO) enrichment analysis. Western blot analysis confirmed that CA reduced the expression of IL-17, matrix metallopeptidase 9 (MMP9), cyclooxygenase 2 (COX2), and TNF α in heart tissues and the H9C2 cells. In summary, CA inhibited cardiac inflammation and fibrohypertrophy following RH. This effect was closely linked to the expression of MMP9/COX2/TNF α/IL-17. This study sheds light on the therapeutic potential of CA for treating RH-induced myocardial hypertrophy and provides insights into its underlying mechanisms, positioning CA as a promising candidate for future drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, RenovascularNetwork PharmacologyAnimalsMiceMaleDisease Models, AnimalMatrix Metalloproteinase 9Cell LineCyclooxygenase 2Tumor Necrosis Factor-alphaRatsInterleukin-17Angiotensin IISignal TransductionBlood PressureMice, Inbred C57BL

Stichwörter der Autor:innen

MMP9/COX2/TNF α/IL-17coniferyl alcoholinflammatory responsemyocardial hypertrophynetwork pharmacologyrenovascular hypertension

Substanzen

Matrix Metalloproteinase 9Cyclooxygenase 2Tumor Necrosis Factor-alphaInterleukin-17Angiotensin II

Autor:innen und Institutionen

  • Natural and Biomimetic Medicine Research Center, Tissue-Orientated Property of Chinese Medicine Key Laboratory of Sichuan Province, West China School of Medicine, West China Hospital, Sichuan University, Chengdu 610000,…
  • Innovative Chinese Medicine Academician Workstation, West China Hospital, Sichuan University, Chengdu 610000, China.

ORCID-Profile: Tao Wang, Yu Gao

Förderung

  • the Innovative Chinese Medicine and Health Products Research Academician Workstation of Academicians Boli Zhang and Beiwei Zhu of the West China Hospital, Sich…
  • the 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University
  • the Innovative Chinese Medicine Preclinical Research Fund of "Liqing No.2", West China Hospital, Sichuan University
  • Innovative Chinese Medicine and Health Products Research Academician Workstation of Academicians Boli Zhang and Beiwei Zhu of the West China Hospital, Sichuan…
  • 135 Project for Disciplines of Excellence, West China Hospital, Sichuan University
  • Innovative Chinese Medicine Preclinical Research Fund of “Liqing No.2”, West China Hospital, Sichuan University

Zitieren

APA

Wu, Q., Zhou, Q., Wan, C., Xin, G., Wang, T., Gao, Y., Liu, T., Yu, X., Zhang, B., & Huang, W. (2024). Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810063

Vancouver

Wu Q, Zhou Q, Wan C, Xin G, Wang T, Gao Y, et al. Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810063

BibTeX
@article{Wu2024,
  author = {Wu, Qiuling and Zhou, Qilong and Wan, Chengyu and Xin, Guang and Wang, Tao and Gao, Yu and Liu, Ting and Yu, Xiuxian and Zhang, Boli and Huang, Wen},
  title = {Mechanism Actions of Coniferyl Alcohol in Improving Cardiac Dysfunction in Renovascular Hypertension Studied by Experimental Verification and Network Pharmacology},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251810063}
}
Kostenlos starten →